Illumina, Inc. (NASDAQ:ILMN) Annual Evercore ISI HealthCONx Healthcare Conference December 3, 2024 9:00 AM ET
Company Participants
Ankur Dhingra – CFO
Sallilyn Schwartz – VP of Investor Relations
Conference Call Participants
Vijay Kumar – Evercore ISI
Vijay Kumar
Great. Thanks, everyone, for joining us this afternoon. I’m Vijay Kumar, a life science device analyst here at Evercore. Pleasure to have with us Illumina. We have Ankur Dhingra, CFO; and from Investor Relations, we have Salli Schwartz. Ankur, Salli, thanks for the time this afternoon.
Ankur Dhingra
Yes. Thanks, Vijay. Thanks for the opportunity to come talk to the investors here.
Vijay Kumar
Yes. I’ve been waiting since morning to have this conversation, so…
Ankur Dhingra
Okay. All right.
Question-and-Answer Session
Q – Vijay Kumar
No, it’s — maybe just to level set, I thought, look, the third quarter was fine. I thought consumables came in a little bit better. Maybe instruments a little bit softer, but from your internal models, Ankur, when you do the review, were there any surprises? Anything that stood out in the third quarter for you guys?
Ankur Dhingra
Yes, that’s a great question. Let me just frame how Q3 shaked out for us, and kind of been here six months now, so that was also the second complete quarter for me as well. And I’m very pleased with the progress that we’re making as a company and with our flagship product. We’re still in transition, and the company is in transformation. But very happy with how last couple of quarters have shaked out both from the transition on X, our high-throughput consumable business, the way it is progressing as well as the operating discipline culture that is beginning to reflect within the numbers as well on the margin side.
So good progress. A lot of work
Read the full article here